ResultsIQ

ResultsIQ › Latest results › Royal Orchid Hotels Limited

Royal Orchid Hotels Limited Q2 FY26 earnings call summary

NSE: ROHLTD · BSE: 532699

Earnings call of 17 Nov 2025, summarised by AI from the filing.

₹25 cr in Q2 including ₹3 cr ICONIQA pre-opening; ₹25-25.5 cr new normal.

Key takeaways

  1. Employee cost ₹25 cr in Q2 including ₹3 cr ICONIQA pre-opening; ₹25-25.5 cr new normal.
  2. Vision 2030 Triple portfolio to 345 hotels and 22,000-plus keys by 2030.
  3. Goa renovation Delayed by land use court issue; work to start in April.

Original filing on BSE

Royal Orchid Hotels Limited Q1 FY27 results

As filed: Revenue ₹107 cr (+36% year on year), EBITDA ₹25.4 cr (+27% year on year), PAT ₹6.8 cr (−38% year on year), EBITDA margin 23.7% (−159 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹113 cr (+30% year on year), EBITDA ₹1.1 cr (−94% year on year), PAT ₹8.2 cr (−57% year on year), EBITDA margin 1.0% (−1,000 bps). Score 26 of 100, Below trend. Revenue growth was well above the company's own trend; EBITDA and profit before exceptional items growth were well below it. EBITDA margin fell 1000 bps year on year. Other income 64% of PBT. Consolidated profit -37% but standalone +396%. Profit fell 34% from last quarter. Share price after the results: +0.2% in 30 days (Nifty 500: +0.9%).
  • Q3 FY26: Revenue ₹113 cr (+27% year on year), EBITDA ₹29.9 cr (+20% year on year), PAT ₹9.6 cr (−47% year on year), EBITDA margin 26.5% (−160 bps). Score 66 of 100, Above trend. Revenue growth was well above the company's own trend; EBITDA growth was above it; profit growth was well below it. EBITDA margin fell 160 bps year on year. Other income 47% of PBT. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: −14.0% in 30 days (Nifty 500: −7.8%).
  • Q2 FY26: Revenue ₹79.0 cr (+13% year on year), EBITDA ₹13.0 cr (+18% year on year), PAT ₹4.0 cr (−50% year on year), EBITDA margin 16.5% (+74 bps). Score 47 of 100, In line with trend. Revenue and EBITDA growth were above the company's own trend; profit growth was well below it. EBITDA margin rose 74 bps year on year. Other income 200% of PBT. Profit fell 64% from last quarter. Share price after the results: −14.9% in 30 days (Nifty 500: −0.5%).
  • Q1 FY26: Revenue ₹79.0 cr (+8% year on year), EBITDA ₹20.0 cr (+25% year on year), PAT ₹11.0 cr (+22% year on year), EBITDA margin 25.3% (+340 bps). Score 61 of 100, In line with trend. Revenue growth was in line with the company's own trend; EBITDA and profit growth were well above it. EBITDA margin rose 340 bps year on year. Other income 27% of PBT. Revenue fell 9% from last quarter. Share price after the results: +23.0% in 30 days (Nifty 500: +2.2%).
  • Q4 FY25: Revenue ₹87.0 cr (+14% year on year), EBITDA ₹19.0 cr (+12% year on year), PAT ₹13.0 cr (−24% year on year), EBITDA margin 21.8% (−53 bps). Score 54 of 100, In line with trend. Revenue growth was well above the company's own trend; EBITDA growth was above it; profit growth was well below it. EBITDA margin fell 53 bps year on year. Other income 38% of PBT. Profit fell 28% from last quarter. Share price after the results: +0.5% in 30 days (Nifty 500: +2.7%).
  • Q3 FY25: Revenue ₹89.0 cr (+9% year on year), EBITDA ₹25.0 cr (0% year on year), PAT ₹18.0 cr (+13% year on year), EBITDA margin 28.1% (−240 bps). Score 51 of 100, In line with trend. Revenue and EBITDA growth were in line with the company's own trend; profit growth was above it. EBITDA margin fell 240 bps year on year. Other income 27% of PBT.
  • Q2 FY25: Revenue ₹70.0 cr (+4% year on year), EBITDA ₹11.0 cr (−35% year on year), PAT ₹8.0 cr (0% year on year), EBITDA margin 15.7% (−966 bps). Score 14 of 100, Below trend. EBITDA margin fell 966 bps year on year. Other income 80% of PBT. Not enough history for a trend yet: scored on growth alone. Revenue fell 4% from last quarter.

Past price moves after results do not indicate future moves. Not a recommendation.

Royal Orchid Hotels Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.